Expression of MHC Molecules and ICAM-1 on Non-small Cell Lung Carcinomas: Association with Early Lymphatic Spread of Tumour Cells

European Journal of Cancer

Volumn 32, Issue 1, 1996, Pages 141-145

  Passlick, B ^a   Pantel, K ^a   Kubuschok, B ^a   Angstwurm, M ^a   Neher, A ^c   Thetter, O ^a   Schweiberer, L ^a   Izbicki, J R ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

^c NONE

Author keywords

ICAM 1; Lung cancer; MHC molecules; Micrometastases

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL; FEMALE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL;

ADULT; AGED; BONE MARROW NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HLA ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERCELLULAR ADHESION MOLECULE-1; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS;

EID: 0029915993     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00551-X     Document Type: Article

References (19)

1. Passlick B, Izbicki JR, Kubuschok B, et al. Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small cell lung cancer. J Clin Oncol 1994, 12, 1827-1832.
2. Pantel K, Izbicki JR, Angstwurm M, et al. Immunocytological detection of bone marrow micrometastasis in operable non-small cell lung cancer. Cancer Res 1993, 53, 1027-1031.
3. Dustin ML, Rothlein, R, Bhan AK, Dinarello CA, Springer TA. Induction by IL-1 and interferon-j: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986, 137, 245-254.
4. Webb DSA, Mostowski HS, Gerrard TL. Cytokine-induced enhancement of ICAM-1 expression results in increased vulnerability of tumour cells to monocyte-mediated lysis. J Immunol 1991, 146, 3682-3686.
5. Braakman E, Goedebuure PS, Vreugdenhill RJ, Segal DM, Shaw S, Bolhiuis RLH. ICAM-melanoma cells are relatively resistant to CD3-mediated T-cell lysis. IntJ Cancer 1990, 46, 475-480.
6. Passlick B, Izbicki JR, Simmel S, et al. Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: frequency and prognostic significance. Eur J Cancer 1994, 30A, 376-381.
7. Redondo M, Concha R, Oldiviela A, et al. Expression of HLA class I and class II antigens in bronchogenic carcinoma: its relationship to cellular DNA content and clinical-pathological parameters. Cancer Res 1991, 51, 4948-4954.
8. Bernstable CJ, Bodmer WF, Brown G, Galfre G, Milstein C, Williams AF. Production of monoclonal antibodies to group A erythrocytes, HLA and other cell surface antigens - a new tool for genetic analysis. Cell 1979, 14, 9-20.
9. Adams TE, Bodmer JG, Bodmer WF. Production and characterisation of monoclonal antibodies recognizing the alpha-chain subunits of human Iaalloantigens. Immunology 1983, 50, 613-624.
10. Johnson JP, Stade G, Hupke U, Holzmann B, Riethmüller G. The melanoma progression-associated antigen P3.58 is identical to the intercellular adhesion molecule ICAM-1. Immunobiol 1988, 178, 275-284.
11. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990, 43, 213-219.
12. Debus E, Moll R, Franke WW, Weber K, Osborn M. Immunohistochemical distinction of human carcinomas by cytokeratin typing with monoclonal antibodies. Am J Pathol 1984, 114, 121-130.
13. Cordell JL, Falini B, Erber NW, et al. Immunoenzymatic labeling of monoclonal antibodies using immunocomplexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP-complexes). J Hitochem Cytochem 1984, 32, 219-229.
14. Momburg F, Moldenhauer G, Hämmerling G, Möller P. Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res 1987, 47, 2883-2891.
15. Conner A, Stern PL. Loss of MHC class I expression in cervical carcinomas. Int J Cancer 1990, 46, 4712-4715.
16. Möller P, Koretz K, Schlag P, Momburg F. Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD 58) in colorectal carcinoma and its impact on tumor recurrence. Int J Cancer 1991, Suppl. 6, 155-162.
17. Cromme FV, van Bommel PF, Walboomers JM, et al. Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours. Br J Cancer 1994, 69, 1176-1181.
18. Johnson JP, Stade BG, Holzmann B, Schwäble W, Riethmüller G. De novo expression of intercellular adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 1989, 86, 641-644.
19. Harning R, Mainolfi E, Bystryn JC, Henn M, Merluzzi VJ, Rothlein R. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res 1991, 51, 5003-5005.